Vascular bed specific alterations in coagulation and fibrinolytic parameters in young women following myocardial infarction, lacunar cerebral infarction and deep vein thrombosis

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue 2, 2003, Pages 96-101

  Salobir, Barbara ^a   Šabovič, Mišo ^a   Peternel, Polona ^a   Stegnar, Mojca ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Coagulation; Fibrinolysis; Lacunar cerebral infarction; Myocardial infarction; Venous thrombosis; Young women

Indexed keywords

D DIMER; FIBRINOGEN; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; BRAIN INFARCTION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; SEDIMENTATION RATE; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOGENESIS;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION; BRAIN INFARCTION; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; FIBRINOLYSIS; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SLOVENIA; THROMBOSIS; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 0345356203     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073853     Document Type: Article

References (20)

1. Rosenberg RD, Aird WC: Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med1999;340:1555-1564.
2. Zimmerman FH, Cameron A, Fisher LD: Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995;26:654-661.
3. Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM: Thrombosis in the young: Effect of atherosclerotic risk factors on the risk of MI associated with prothrombotic factors. Thromb Haemost1997;78:7-12.
4. Pasricha A, Batchelor W: When young hearts are broken: Profiles of premature myocardial infarction. Am Heart J 2002;143:4-6.
5. Kittner SJ, Stern BJ, Wozniak M, Buchholz DW, Earley CJ, Feeser BR, Johnson CJ, Macko RF, McCarter RJ, Price TR, Sherwin R, Sloan MA, Wityk RJ: Cerebral infarction in young adults: The Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998;50:890-894.
6. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: Description and validation of methods. J Clin Epidemiol 1995;48:1513-1547.
7. Wood D, Backer GD, Faergeman O, Graham I, Mancia G, Pyörä lä K: Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998;19:1434-1503.
8. Anonymous: Myocardial Infarction Community Registers: Results of WHO international collaborative study, Copenhagen, World Health Organisation Regional Office for Europe, 1976.
9. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
10. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-1008.
11. Buckell M: The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J Clin Pathol 1958;11:403-405.
12. Ridker PM, Vaughan DE, Stampfer MJ: Endogenous tissue-type plasminogen activator and the risk of future myocardial infarction. Lancet 1993;341:1165-1168.
13. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996;94:2057-2063.
14. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: The Framingam study. JAMA 1987;258:1183-1186.
15. Quizilbash N, Jones L, Warlow C, Mann J: Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ 1991;303:605-609.
16. Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Olsson T: Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. Stroke 1998;29:2261-2267.
17. Lowe GDO: Etiopathogenesis of cardiovascular disease: Hemostasis, thrombosis and vascular medicine. Ann Periodontol 1998;3:121-126.
18. Alesi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease. Diabetes 1997;46:860-867.
19. Sakamoto T, Woodcock-Mitchell J, Marutsuka K, Mitchell JJ, Sobel BE, Fujii S: TNF-α and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol 1999;276:C1391-C1397.
20. Cigolini M, Tonoli M, Borgato L, Frigotto L, Manzato F, Zeminian S, et al: Expression of plasminogen activator inhibitor-1 in human adipose tissue: A role of TNF-α? Atherosclerosis 1999;143:81-90.